Results 91 to 100 of about 3,475,545 (379)

Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-βRI inhibitor galunisertib. [PDF]

open access: yes, 2020
BackgroundTransforming growth factor beta (TGF-β) signalling is involved in the development of hepatocellular carcinoma (HCC). We followed changes in biomarkers during treatment of patients with HCC with the TGF-βRI/ALK5 inhibitor galunisertib ...
Benhadji, Karim A   +13 more
core   +2 more sources

Plasma Biomarkers and Incident CKD Among Individuals Without Diabetes

open access: yesKidney Medicine, 2023
Rationale & Objective: Biomarkers of kidney disease progression have been identified in individuals with diabetes and underlying chronic kidney disease (CKD).
Dustin Le   +16 more
doaj   +1 more source

A Panel of Plasma Biomarkers for Differential Diagnosis of Parkinsonian Syndromes

open access: yesFrontiers in Neuroscience, 2022
Objective The aim of our study is to explore the most reliable panel of plasma biomarkers for differential diagnosis of parkinsonian syndromes (PDSs).
Qi Li   +9 more
semanticscholar   +1 more source

A proteomic atlas of senescence-associated secretomes for aging biomarker development. [PDF]

open access: yes, 2020
The senescence-associated secretory phenotype (SASP) has recently emerged as a driver of and promising therapeutic target for multiple age-related conditions, ranging from neurodegeneration to cancer.
Basisty, Nathan   +11 more
core   +1 more source

Advances in blood biomarkers for Alzheimer disease (AD): A review

open access: yesKaohsiung Journal of Medical Sciences
Alzheimer disease (AD) and Alzheimer Disease and Related Dementias (AD/ADRD) are growing public health challenges globally affecting millions of older adults, necessitating concerted efforts to advance our understanding and management of these conditions.
Araya Dimtsu Assfaw   +2 more
doaj   +1 more source

Plasma biomarkers for prognosis of cognitive decline in patients with mild cognitive impairment

open access: yesBrain Communications, 2022
Plasma-based biomarkers present a promising approach in the research and clinical practice of Alzheimer's disease as they are inexpensive, accessible and minimally invasive.
P. Kivisäkk   +11 more
semanticscholar   +1 more source

Changes in vitamin biomarkers during a 2-year intervention trial involving increased fruit and vegetable consumption by free-living volunteers [PDF]

open access: yes, 2009
Peer reviewedPublisher ...
Antonia C. Hardcastle   +11 more
core   +2 more sources

The cytoskeletal control of B cell receptor and integrin signaling in normal B cells and chronic lymphocytic leukemia

open access: yesFEBS Letters, EarlyView.
In lymphoid organs, antigen recognition and B cell receptor signaling rely on integrins and the cytoskeleton. Integrins act as mechanoreceptors, couple B cell receptor activation to cytoskeletal remodeling, and support immune synapse formation as well as antigen extraction.
Abhishek Pethe, Tanja Nicole Hartmann
wiley   +1 more source

Quantitative variability of 342 plasma proteins in a human twin population

open access: yesMolecular Systems Biology, 2015
The degree and the origins of quantitative variability of most human plasma proteins are largely unknown. Because the twin study design provides a natural opportunity to estimate the relative contribution of heritability and environment to different ...
Yansheng Liu   +11 more
doaj   +1 more source

Associations of amyloid and neurodegeneration plasma biomarkers with comorbidities

open access: yesAlzheimer's & Dementia, 2021
Blood‐based biomarkers of amyloid pathology and neurodegeneration are entering clinical use. It is critical to understand what factors affect the levels of these markers.
Jeremy A. Syrjanen   +10 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy